Trial Profile
The Effect of Entecavir Consolidation on Post-TDF Treatment Durability
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 05 May 2022
Price :
$35
*
At a glance
- Drugs Entecavir (Primary)
- Indications Hepatitis B
- Focus Proof of concept; Therapeutic Use
- 17 Oct 2017 New trial record